Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 1475 entries
View as:

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Phase: N/A Priority: Normal
NCT ID: NCT02714855 Org: User:
Start: 10/31/15 End: 12/31/16 Due: 12/31/17

A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00326586 Org: User:
Start: 05/31/06 End: 03/31/09 Due: 03/31/10

A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT03281122 Org: User:
Start: 09/22/17 End: 04/17/19 Due: 04/17/20

Atazanavir Twice Daily

Phase: N/A Priority: Normal
NCT ID: NCT00357721 Org: User:
Start: 06/30/06 End: 09/30/06 Due: 09/30/07

Safety Study of BMS-844421 for Treatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01082562 Org: User:
Start: 04/30/10 End: 07/31/10 Due: 07/31/11

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00104130 Org: User:
Start: 12/31/04 End: 02/28/05 Due: 02/28/06

A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection

Phase: N/A Priority: Normal
NCT ID: NCT03980314 Org: User:
Start: 06/24/19 End: 11/06/23 Due: 11/06/24

Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00135421 Org: User:
Start: 11/30/05 End: 10/31/07 Due: 10/31/08

Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00364793 Org: User:
Start: 02/28/07 End: 07/31/13 Due: 07/31/14

Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00803556 Org: User:
Start: 01/31/06 End: 08/31/09 Due: 08/31/10

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00623766 Org: User:
Start: 07/31/08 End: 10/31/12 Due: 10/31/13

Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib

Phase: N/A Priority: Normal
NCT ID: NCT00320190 Org: User:
Start: 08/31/06 End: 01/31/10 Due: 01/31/11

A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates

Phase: N/A Priority: Normal
NCT ID: NCT02762123 Org: User:
Start: 05/31/16 End: 08/31/16 Due: 08/31/17

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02253992 Org: User:
Start: 09/29/14 End: 05/24/19 Due: 05/24/20

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00095394 Org: User:
Start: 09/30/04 End: 05/31/05 Due: 05/31/06

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02159365 Org: User:
Start: 03/08/14 End: 07/11/18 Due: 07/11/19

An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03924427 Org: User:
Start: 04/10/19 End: 03/24/21 Due: 03/24/22

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00162201 Org: User:
Start: 10/31/03 End: 04/30/05 Due: 04/30/06

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Phase: N/A Priority: Normal
NCT ID: NCT01721759 Org: User:
Start: 11/16/12 End: 04/22/21 Due: 04/22/22

Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00050596 Org: User:
Start: 11/30/02 End: 11/30/04 Due: 11/30/05

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

Phase: N/A Priority: Normal
NCT ID: NCT03357731 Org: User:
Start: 11/30/17 End: 05/10/19 Due: 05/10/20

A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

Phase: N/A Priority: Normal
NCT ID: NCT02538874 Org: User:
Start: 10/31/15 End: 11/05/16 Due: 11/05/17

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00002418 Org: User:
Start: - End: - Due: -

A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I

Phase: N/A Priority: Normal
NCT ID: NCT01142700 Org: User:
Start: 07/31/10 End: 12/31/10 Due: 12/31/11

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00441337 Org: User:
Start: 08/31/06 End: 11/30/09 Due: 11/30/10